share_log

Early Warning Press Release In Respect of ReGen III Corp.

Early Warning Press Release In Respect of ReGen III Corp.

關於 Regen III Corp. 的預警新聞稿
newsfile ·  2023/12/20 20:55

This press release is issued pursuant to National Instrument 62-104 - Take-Over Bids and Issuer Bids and National Instrument 62-103 - The Early Warning System and Related Take-Over Bid and Insider Reporting Issues.

本新聞稿根據National Instrument 62-104——收購投標和發行人出價以及National Instrument 62-103——預警系統及相關的收購出價和內幕報告問題發佈的。

Vancouver, British Columbia--(Newsfile Corp. - December 20, 2023) - Brad White ("White" or the "Acquiror") of Toronto, ON reports that he has acquired ownership or control over 145 convertible debenture units (each a "Unit") of ReGen III Corp. ("ReGen") in a private placement, which closed in two tranches - November 17, 2023, and December 20, 2023 (the "Private Placement"). Each Unit consists of CAD$1,000 in principal amount of unsecured convertible debenture (a "Debenture") and 1,000 common share purchase warrants (a "Warrant"). Each Warrant is exercisable to purchase one common share at a price of CAD$0.55 for a period of 24 months after closing.

不列顛哥倫比亞省溫哥華--(Newsfile Corp.,2023 年 12 月 20 日)-布拉德·懷特(”白色“或者”收購者安大略省多倫多市的 “)報告說,他已經獲得了145個可轉換債券單位的所有權或控制權(每個單位爲”單元“) 的 ReGen III Corp. (”RegEN“) 進行私募配售,分兩批收盤——2023 年 11 月 17 日和 2023 年 12 月 20 日(私募配售“)。每個單位由本金1,000加元的無抵押可轉換債券組成(a”債券“) 和 1,000 份普通股購買認股權證 (a”搜查令“)。每份認股權證均可在收盤後24個月內以0.55加元的價格行使購買一股普通股。

This acquisition represents approximately 4.83% of the total number of Debentures and Warrants issued in the Private Placement, and which if immediately converted and exercised respectively by White as of today's date would result in the issue to him of 408,636 common shares representing approximately 0.34% of the then issued and outstanding common shares. The 145 Units acquired by White were purchased at a price of $1,000 per Unit for total consideration of $145,000 paid in cash.

此次收購約佔私募發行的債券和認股權證總數的4.83%,如果懷特從今天起分別進行轉換和行使,將導致向他發行408,636股普通股,約佔當時已發行和流通普通股的0.34%。懷特收購的145套單位是以每套1,000美元的價格購買的,以現金支付的總對價爲14.5萬美元。

Prior to the Private Placement, White beneficially owned, controlled, or directed an aggregate of 12,614,090 common shares, 666,750 share purchase warrants, and 700,000 stock options, representing approximately 10.66% of the outstanding common shares of ReGen on a non-diluted basis and approximately 11.68% on a partially diluted basis, assuming White's exercise of his warrants and stock options. Following the Private Placement, White beneficially owns, controls, or directs an aggregate of 12,614,090 common shares, 811,750 share purchase warrants, 700,000 stock options, and 145 Debentures representing approximately 10.66% of the outstanding common shares of ReGen on a non-diluted basis and approximately 11.98% on a partially diluted basis, assuming White's exercise of his warrants, stock options, and conversion and exercise of his convertible debentures.

在私募之前,懷特共實益擁有、控制或定向了12,614,090股普通股、666,750份股票購買權證和70萬份股票期權,假設懷特行使認股權證和股票期權,未攤薄後約佔ReGen已發行普通股的10.66%,部分攤薄後約佔11.68%。私募後,懷特在未稀釋基礎上實益擁有、控制或指導共計12,614,090股普通股、811,750份股票購買權證、70萬份股票期權和145份債券,假設懷特行使認股權證、股票期權以及轉換和行使可轉換股票,佔ReGen已發行普通股的10.66%,部分攤薄後約佔11.98% 債券。

White acquired the Units for investment purposes. White may, depending on market or other conditions, increase or decrease his beneficial ownership, control or direction over, or exercise its current rights to acquire, common shares through market transactions, private agreements or otherwise.

懷特出於投資目的收購了這些單位。根據市場或其他條件,懷特可能會通過市場交易、私人協議或其他方式增加或減少其對普通股的受益所有權、控制權或指導,或行使目前收購普通股的權利。

An early warning report will be electronically filed by White with the applicable securities commission in each jurisdiction where ReGen is reporting and will be available on Sedar Plus at . For more information, please contact Brad White at (416) 419-1962.

懷特將以電子方式向Regen報告的每個司法管轄區的相關證券委員會提交預警報告,並將在Sedar Plus上公佈,網址爲。欲了解更多信息,請致電 (416) 419-1962 與布拉德·懷特聯繫。

(signed) "Brad White"
Brad White

(簽名)”布拉德·懷特”
布拉德·懷特

To view the source version of this press release, please visit

要查看本新聞稿的源版本,請訪問

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論